Patent · US Active

Cell differentiation inducer

US8026239B2 · kind B2 · utility

0Cited by

3References

1Claims

0Family size

Assignee

Bayer Schering Pharma AG · DE

Inventors

Tsuneji Suzuki · Chiba, JP
Tomoyuki Ando · Chiba, JP
Katsutoshi Tsuchiya · Chiba, JP
Osamu Nakanishi · Ashiya, JP
Akiko Saito · Machida, JP
Takashi Yamashita · Nagareyama, JP
Yoshinori Shiraishi · Yokohama, JP
Eishi Tanaka · Chiba, JP

Key dates

Filing date	Mar 11, 2010
Grant date	Sep 27, 2011
Priority date	—
Expiry date	Mar 11, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A method of treating a malignant tumor selected from the group consisting of leukemia, colorectal cancer, ovarian cancer, oral cancer, lung carcinoma, breast carcinoma, prostate carcinoma, and melanoma by administering to a patient in need thereof an effective amount of at least one compound represented by formula (1)wherein A, X, Q, R1-3, and n are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.